Serum institute CEO expects Omicron-specific vaccine in 6 months: Report
New Delhi: Serum Institute of India's (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six months, NDTV reported on Monday.
Read also: SII conducting research to find vaccine against Monkeypox, says Adar Poonawalla
SII, the world's biggest vaccine maker, produces AstraZeneca's COVID-19 vaccine under the brand name Covishield.
SII did not immediately respond to a Reuters request for comment.
Next Story